论文部分内容阅读
本文探讨注射用血栓通临床治疗效果,为提高患者疗效提供可靠依据,最终保障患者生活质量与生命安全,现报告如下。1临床资料共选取120例患者使用注射用血栓通治疗,其中男78例,女42例;年龄35-72岁,平均年龄为(46.37±1.03)岁;疾病类型:高血压缺血性中风患者112例,玻璃体积血患者8例。2治疗方法高血压缺血性中风、慢性乙型肝炎以及玻璃体积
This article discusses the clinical effect of injection of thrombosis, to provide a reliable basis for improving the efficacy of patients, and ultimately ensure the quality of life of patients and life safety, are as follows. 1 clinical data were selected 120 patients treated with injection of thrombus, including 78 males and 42 females; aged 35-72 years, mean age (46.37 ± 1.03) years of age; type of disease: hypertensive ischemic stroke patients 112 cases, vitreous hemorrhage in 8 cases. 2 treatment of hypertension ischemic stroke, chronic hepatitis B and glass volume